3637 results for «208»
3637 results
Transcatheter mitral valve replacement - LIVE case
20 May 2026 – From EuroPCR 2026
A 65‑year‑old woman with obesity (BMI 38.7), prior cardiac surgery (CABG to OM and LAD in 2012), and chronic kidney disease presented with symptomatic severe mitral regurgitation (Carpentier type III: type IIIa due to calcification and type IIIb post‑MI) with moderately reduced LVEF (45%).
A transcatheter mitral...
Combined mitral repair and LAA closure with two separate septal punctures - LIVE case
21 May 2026 – From EuroPCR 2026
A 79‑year‑old man with hypertension, a history of basal cell carcinoma and psoriasis, presented with symptomatic severe primary MR (flail P2 due to ruptured chordae) and bleeding complications (recurrent skin bleeding) while on DOAC therapy for permanent atrial fibrillation.
Two G5 MitraClip devices were implanted. Subsequently, through...
TAVI in aortic regurgitation with a dedicated valve - LIVE case
20 May 2026 – From EuroPCR 2026
An 80-year-old male with chronic kidney disease, a history of colon cancer (2013), paroxysmal AF, and LAD PCI 2 weeks earlier presented with symptomatic severe type III AR. He had normal LV function, but early LV dilation. The mechanism of AR was a combination of primary...
FFR- and IVUS-guided PCI of a long and calcified LAD lesion - LIVE case
19 May 2026 – From EuroPCR 2026
A 71‑year‑old man with hypertension and dyslipidemia presented with CCS class II angina and three‑vessel coronary artery disease. Functional assessment included CT‑derived micro‑FFR, angiography‑based FFR, and stress myocardial scintigraphy. The only hemodynamically significant lesion was a long, calcified lesion of the LAD.
Lesion preparation was performed with...
TAVI and coronary artery disease - LIVE case
19 May 2026 – From EuroPCR 2026
An 88-year-old woman with hypertension, dyslipidemia, paroxysmal AF, and moderate renal impairment presented with symptomatic severe aortic stenosis, with a small (396 mm²), horizontal annulus and preserved LV function. She also had CAD with severe OM and diagonal stenoses. CT showed a risk of left main...
TAVI in extensive valve calcifications - LIVE case
22 May 2026 – From EuroPCR 2026
An 88‑year‑old woman with a history of dual‑chamber PPM and prior radiotherapy for breast cancer presented with symptomatic aortic stenosis and preserved left ventricular function.
A 27 mm Navitor Vision valve was implanted under local anesthesia using dual arterial access (femoral and right radial arteries).
LIVE Educational Case...
TAV-in-SAV TAVI procedure - LIVE case
21 May 2026 – From EuroPCR 2026
A 70‑year‑old man with COPD and a history of severe aortic stenosis treated with SAVR (27 mm Perimount Magna) in 2012, followed by endocarditis in 2013, presented with symptomatic degeneration of the surgical valve, predominantly as severe aortic regurgitation. Left ventricular function was preserved (LVEF 50%)...
PCI of calcified distal left main stenosis - LIVE case
19 May 2026 – From EuroPCR 2026
A 54 year-old male with hypertention, smoker, dyslipidemia and history of OM and Diagnal PCI (2004) presented a significant LM-LAD calcified stenosis.
They prepared the proximal LAD lesion by IVL before implanted a 3.5-28 mm stent. Then, they prepared the LM lesion with NC predilatation, a cutting...
Calcified lesion of distal protected left main - LIVE case
22 May 2026 – From EuroPCR 2026
An 85‑year‑old man with type 2 diabetes mellitus, hypertension, dyslipidemia, peripheral artery disease, COPD, and chronic kidney disease presented with CCS class II angina related to three‑vessel coronary artery disease. He had previously undergone hybrid revascularization, including PCI of the RCA ostium and CABG with LIMA...
Jupiter Endovascular announces positive results from SPIRARE I first-in-human study presented at TCT 2025
26 Oct 2025
Redo-surgery versus transcatheter valve-in-valve for mitral bioprosthetic dysfunction: The SURVIV trial
03 Apr 2026
Yohei Ohno provides his takeaways from the results of the SURVIV trial, which were presented by Dimytri Siqueira during the ACC.26 in New Orleans.
Author
ECLS-SHOCK: venoarterial membrane oxygenation in cardiogenic shock
27 Aug 2023
Panos Xaplanteris & Leonidas Koliastasis provide their take on the final results of the ECLS-SHOCK (Extracorporeal Life Support in Infarct-Related Cardiogenic Shock) which were presented by Holger Thiele during the ESC 2023 congress in Amsterdam.
Author
Author
Complicated subendothelial dissection during left anterior descending coronary artery – first diagonal branch bifurcation treatment with Culotte technique
06 Jan 2025
Learn more about troubleshooting and tailor-made treatment combining 2D and 3D OCT thanks to this image in cardiology!
Randomised comparison of intravascular lithotripsy vs. cutting balloon treatment in calcified coronary artery disease – The Short-CUT trial
27 Oct 2025
Aaysha Cader provides her take on the Short-CUT trial presented by Suzanne J. Baron at TCT 2025, in San Francisco.
Author
Five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial
26 Oct 2023
Alex Sticchi provides his take on the 5-year outcomes from PARTNER 3 Low Risk which were presented by Martin B. Leon at TCT Congress 2023.
Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
ILUMIEN IV: OPTIMAL PCI - Optical Coherence Tomography Guided Coronary Stent Implantation Compared with Angiography: A Multicenter Randomized Trial in Percutaneous Coronary Intervention
29 Aug 2023
Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...
Author
Author
